Print

Momenta Pharmaceuticals, Inc. (MNTA) Reports Third Quarter 2012 Financial Results  
11/7/2012 9:16:15 AM

CAMBRIDGE, Mass., Nov. 7, 2012 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today reported its financial results for the quarter ended September 30, 2012.
//-->